Top story

CPHI Milan: Why One Reliable Supplier Isn't Enough

Read full story

BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation

Pharmaceutical Technology

Wed, 30 Apr 2025

Industry Outlook 2025: European Geopolitical Impact on Pharma

Pharmaceutical Technology

Wed, 30 Apr 2025

FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

Pharmaceutical Technology

Wed, 30 Apr 2025

FDA approves Abeona’s $3.1m cell therapy for rare skin disease

Pharmaceutical Technology

By Jenna Philpott - Wed, 30 Apr 2025

Magazine: The GLP-1 shortage is over. What’s next for compounders?

Pharmaceutical Technology

By Ross Law - Wed, 30 Apr 2025

Boehringer, Oxford University and Cumulus to explore brain activity in BPD

Pharmaceutical Technology

By gullapalli - Wed, 30 Apr 2025

Construction begins on MSD’s $1bn biologics centre in Delaware, US

Pharmaceutical Technology

By gullapalli - Wed, 30 Apr 2025

Biopharma venture financing declines 20.2% YOY in Q1 2025 amid persistent investor caution

Pharmaceutical Technology

By GlobalData Healthcare - Wed, 30 Apr 2025

Donald Trump’s first 100 days: Impact on the healthcare industry

Pharmaceutical Technology

By Ross Law - Wed, 30 Apr 2025